Abvc Biopharma (ABVC) Net Margin (2009 - 2026)
Abvc Biopharma's Net Margin was -1679.89% in Q2 2026.
Powered by 
Analysis
Abvc Biopharma (ABVC) Net Margin (2009 - 2026) Analysis & Trends
For FY2025, Net Margin at Abvc Biopharma came in at -24886.10%, down 25918.12 percentage points from FY2024.
- Net Margin shows a five-year change of -22693.02 percentage points (FY2020 to FY2025).
- In earlier years, Net Margin was 1032.02% in FY2024 (+8154.40 pp), -7122.39% in FY2023 (-5428.89 pp), -1693.50% in FY2022 (+1914.97 pp) and -3608.47% in FY2021 (-1415.38 pp).
- The Q2 2026 figure marks the highest quarterly Net Margin since Q4 2024.
- The best year-over-year quarter for Net Margin over five years was Q4 2024 (a gain of 687988.91 percentage points); the worst was Q1 2024 (a drop of 241537.93 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 19.55% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,679.89% |
| Dec 31, 2024 | 528,546.24% |
| Sep 30, 2024 | -47.93% |
| Jun 30, 2024 | -864.46% |
| Mar 31, 2024 | -242,959.67% |
| Dec 31, 2023 | -159,442.68% |
| Sep 30, 2023 | -20,885.90% |
| Jun 30, 2023 | -37,052.07% |
| Mar 31, 2023 | -1,421.74% |
| Dec 31, 2022 | -825.80% |
| Sep 30, 2022 | -8,764.97% |
| Jun 30, 2022 | -594.19% |
| Mar 31, 2022 | -23,364.93% |
| Sep 30, 2021 | -1,824.75% |
| Jun 30, 2021 | -6,270.68% |
| Mar 31, 2021 | -454.24% |
| Dec 31, 2020 | -7,989.86% |
| Sep 30, 2020 | -1,844.29% |
| Jun 30, 2020 | -816.42% |
| Mar 31, 2020 | -1,583.45% |
API Access
Abvc Biopharma Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();